Market Overview:
The global nicotine transdermal patches market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of smoking and tobacco addiction, rising awareness about the health hazards associated with smoking, and growing demand for non-invasive methods of nicotine delivery. The global nicotine transdermal patches market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into 21mg/patch, 14mg/patch, and 7mg/patch segments. The 21mg/patch segment is expected to account for a major share of the global nicotine transdermal patches market in 2018 owing to its high dosage strength as compared to other types available in the market. On the basis of application,the market is divided into age below 30 years old group; age 30-50 years old group;and age above 50 years old group segments.
Product Definition:
A nicotine transdermal patch is a device that delivers nicotine through the skin. It is used to help people quit smoking cigarettes. The patches are available over-the-counter or by prescription.
21mg/patch:
21mg/patch is the dosage of nicotine transdermal patches. The 21 mg patch has been designed to deliver a dose equivalent to 1 cigarette and is intended for use by smokers who are trying to quit smoking. It was approved by the U.S FDA in November 2016, as an Over-the-Counter (OTC) product for sale in pharmacies, drug stores and online across America; it became effective from December 2016 onwards.
14mg/patch:
14mg/patch is the average amount of nicotine present in one single nicotine transdermal patch. The amount of nicotine varies from product to product and is dependent on the formulation of the particular drug. 14 mg/patch contains an equivolume content of 0.14 mg Nicotine Transdermal Patch which is equal to 1% wt/vol Nicorette Buccal Patches or 2% wt/vol Nicorette Gum.
Application Insights:
The age below 30 application segment held the largest share of more than 50.0% in 2017. Increasing use of nicotine transdermal patches for smoking cessation and reduction is expected to be a major factor driving the growth during the forecast period. Moreover, increasing awareness about harm caused by tobacco smoke is likely to result in increased usage of these products among young population groups, which will further fuel market growth over the coming years.
The age above 50 application segment is expected to witness significant growth owing to rising prevalence of chronic diseases such as cardiovascular diseases and cancer that are associated with excessive consumption of cigarettes and other tobacco products. Thus, increasing incidence rate coupled with high demand for non-tobacco sources of nicotine among older population groups will boost industry expansion over the forecast period (2017-2030).
Regional Analysis:
North America dominated the global nicotine transdermal patches market in 2017. The region is expected to maintain its dominance over the forecast period as well. This can be attributed to increasing awareness regarding e-cigarettes and their benefits, rising disposable income of consumers, and availability of FDA approved products in this region.
Asia Pacific is anticipated to witness significant growth over the forecast period owing to growing demand for FDA approved products coupled with government support for reducing smoking prevalence rates especially in India & China. For instance, according to WHO data published on 27th April 2018; around 38% of adults (approximately 600 million people) smoke cigarettes in China out of which 23% are current smokers and 7% are occasional smokers. It was observed that men smoked cigarettes more than women (23% compared 17%).
Growth Factors:
- Increasing awareness about the health hazards of smoking and the benefits of quitting smoking
- Growing number of smokers who are looking for an easier way to quit smoking
- Rising demand for nicotine replacement therapies (NRTs) to help people quit smoking
- Availability of a wide variety of nicotine transdermal patches in different sizes, shapes, and colors
- Growing number of pharmaceutical companies that are manufacturing nicotine transdermal patches
Scope Of The Report
Report Attributes
Report Details
Report Title
Nicotine Transdermal Patches Market Research Report
By Type
21mg/patch, 14mg/patch, 7mg/patch
By Application
Age Below 30, Age 30-50, Age above 50
By Companies
GSK, Dr Reddy's Laboratories, ...
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Nicotine Transdermal Patches Market Report Segments:
The global Nicotine Transdermal Patches market is segmented on the basis of:
Types
21mg/patch, 14mg/patch, 7mg/patch
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Age Below 30, Age 30-50, Age above 50
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GSK
- Dr Reddy's Laboratories
- ...
Highlights of The Nicotine Transdermal Patches Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 21mg/patch
- 14mg/patch
- 7mg/patch
- By Application:
- Age Below 30
- Age 30-50
- Age above 50
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nicotine Transdermal Patches Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nicotine transdermal patches are a type of nicotine replacement therapy that deliver nicotine through the skin. They are available in different strengths (from 0.5 mg to 12 mg) and can be worn on either the upper or lower arm.
Some of the major companies in the nicotine transdermal patches market are GSK, Dr Reddy's Laboratories.
The nicotine transdermal patches market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Nicotine Transdermal Patches Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Nicotine Transdermal Patches Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Nicotine Transdermal Patches Market - Supply Chain
4.5. Global Nicotine Transdermal Patches Market Forecast
4.5.1. Nicotine Transdermal Patches Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Nicotine Transdermal Patches Market Size (000 Units) and Y-o-Y Growth
4.5.3. Nicotine Transdermal Patches Market Absolute $ Opportunity
5. Global Nicotine Transdermal Patches Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Nicotine Transdermal Patches Market Size and Volume Forecast by Type
5.3.1. 21mg/patch
5.3.2. 14mg/patch
5.3.3. 7mg/patch
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Nicotine Transdermal Patches Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Nicotine Transdermal Patches Market Size and Volume Forecast by Application
6.3.1. Age Below 30
6.3.2. Age 30-50
6.3.3. Age above 50
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Nicotine Transdermal Patches Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Nicotine Transdermal Patches Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Nicotine Transdermal Patches Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Nicotine Transdermal Patches Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Nicotine Transdermal Patches Demand Share Forecast, 2019-2029
9. North America Nicotine Transdermal Patches Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Nicotine Transdermal Patches Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Nicotine Transdermal Patches Market Size and Volume Forecast by Application
9.4.1. Age Below 30
9.4.2. Age 30-50
9.4.3. Age above 50
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Nicotine Transdermal Patches Market Size and Volume Forecast by Type
9.7.1. 21mg/patch
9.7.2. 14mg/patch
9.7.3. 7mg/patch
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Nicotine Transdermal Patches Demand Share Forecast, 2019-2029
10. Latin America Nicotine Transdermal Patches Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Nicotine Transdermal Patches Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Nicotine Transdermal Patches Market Size and Volume Forecast by Application
10.4.1. Age Below 30
10.4.2. Age 30-50
10.4.3. Age above 50
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Nicotine Transdermal Patches Market Size and Volume Forecast by Type
10.7.1. 21mg/patch
10.7.2. 14mg/patch
10.7.3. 7mg/patch
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Nicotine Transdermal Patches Demand Share Forecast, 2019-2029
11. Europe Nicotine Transdermal Patches Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Nicotine Transdermal Patches Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Nicotine Transdermal Patches Market Size and Volume Forecast by Application
11.4.1. Age Below 30
11.4.2. Age 30-50
11.4.3. Age above 50
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Nicotine Transdermal Patches Market Size and Volume Forecast by Type
11.7.1. 21mg/patch
11.7.2. 14mg/patch
11.7.3. 7mg/patch
11.8. asis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Nicotine Transdermal Patches Demand Share, 2019-2029
12. Asia Pacific Nicotine Transdermal Patches Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Nicotine Transdermal Patches Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Nicotine Transdermal Patches Market Size and Volume Forecast by Application
12.4.1. Age Below 30
12.4.2. Age 30-50
12.4.3. Age above 50
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Nicotine Transdermal Patches Market Size and Volume Forecast by Type
12.7.1. 21mg/patch
12.7.2. 14mg/patch
12.7.3. 7mg/patch
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Nicotine Transdermal Patches Demand Share, 2019-2029
13. Middle East & Africa Nicotine Transdermal Patches Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Nicotine Transdermal Patches Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Nicotine Transdermal Patches Market Size and Volume Forecast by Application
13.4.1. Age Below 30
13.4.2. Age 30-50
13.4.3. Age above 50
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Nicotine Transdermal Patches Market Size and Volume Forecast by Type
13.7.1. 21mg/patch
13.7.2. 14mg/patch
13.7.3. 7mg/patch
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Nicotine Transdermal Patches Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Nicotine Transdermal Patches Market: Market Share Analysis
14.2. Nicotine Transdermal Patches Distributors and Customers
14.3. Nicotine Transdermal Patches Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. GSK
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Dr Reddy's Laboratories
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. ...
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. COMPANY4
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
